journal article·2019-12-04Open access

The protective effects of lycopus lucidus turcz in diabetic retinopathy and its possible mechanisms

Jinlu Liu, Sai Bhuvanagiri, Xiaohan Qu

Abstract

The aim of the present study was to investigate the effect of Lycopus lucidus Turcz (LT) on diabetic retinopathy (DR) and its underlying mechanisms. SD rats and human retinal microvascular endothelial cells (HRECs) were applied for establishment DR model. HE and TUNEL staining were used to evaluate the pathological changes and apoptosis of retinal ganglion cells. Additionally, retinal vessels were detected by immunofluorescence staining with CD31 and VEGF. The function of BRB was observed using Evans blue. Moreover, the oxidative stress, inflammation and angiogenesis associated factors were measured respectively. The expression of p38-MAPK/NF-κB signalling proteins were detected by Western blot. The results demonstrated that pathological changes and retinal optic disc cells apoptosis in retinas of diabetic rats, both of which were reduced in the LT-treated group. And LT treatment attenuated the levels of oxidative stress, inflammation and angiogenesis factors. Importantly, the expression levels of p-p38, p-ERK, p-JNK and NF-κB were decreased. After treatment with TNF-α combined with LT, the levels of inflammatory factors were decreased but higher than the negative control. Taken together, the results suggested that LT treatment is of therapeutic benefit by ameliorating oxidative stress, inflammation and angiogenesis of DR via p38-MAPK/NF-κB signaling pathway.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Retinal Diseases and Treatments · Glaucoma and retinal disorders · Neuroinflammation and Neurodegeneration Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Ophthalmology, The Fourth Affiliated Hospital of China Medical University

Queens Hospital Center, Mt. Sinai, Icahn School of Medicine

Department of Thoracic Surgery, The First Hospital of China Medical University

Funding

Nature Science Foundation of Liaoning Province

References (37)

Show source-provided references
1. 10.1155/2013/42425810.1155/2013/424258 ↗
2. 10.1242/dmm.00959710.1242/dmm.009597 ↗
3. 10.1080/1062332021473310.1080/10623320214733 ↗
4. 10.1111/dme.1208910.1111/dme.12089 ↗
5. 10.1136/bjo.86.4.36310.1136/bjo.86.4.363 ↗
6. 10.1155/2013/21313010.1155/2013/213130 ↗
7. 10.1371/journal.pone.010850810.1371/journal.pone.0108508 ↗
8. 10.1016/S0161-6420(03)00475-510.1016/S0161-6420(03)00475-5 ↗
9. 10.1016/j.preteyeres.2011.05.00210.1016/j.preteyeres.2011.05.002 ↗
10. 10.1155/2012/62945210.1155/2012/629452 ↗
11. Aldebasi YH, Rahmani AH, Khan AA. The effect of vascular endothelial growth factor in the progression of bladder cancer and diabetic retinopathy. Int J Clin Exp Med. 2013;6:239–251.
12. 10.1038/nm0603-66910.1038/nm0603-669 ↗
13. 10.1038/nature0708310.1038/nature07083 ↗
14. 10.1016/S0002-9440(10)64869-910.1016/S0002-9440(10)64869-9 ↗
15. 10.1016/j.yexcr.2014.08.04010.1016/j.yexcr.2014.08.040 ↗
16. 10.2174/156652401131306000710.2174/1566524011313060007 ↗
17. 10.1016/j.bmcl.2017.02.04510.1016/j.bmcl.2017.02.045 ↗
18. 10.1038/nm1102-124910.1038/nm1102-1249 ↗
19. 10.1016/j.vph.2007.11.00410.1016/j.vph.2007.11.004 ↗
20. 10.1016/j.phymed.2013.06.00410.1016/j.phymed.2013.06.004 ↗
21. 10.1016/j.foodchem.2015.03.03310.1016/j.foodchem.2015.03.033 ↗
22. 10.1016/j.lfs.2013.05.02410.1016/j.lfs.2013.05.024 ↗
23. 10.2174/13892011179448052510.2174/138920111794480525 ↗
24. 10.4103/0022-3859.9717610.4103/0022-3859.97176 ↗
25. 10.1038/sj.eye.670213810.1038/sj.eye.6702138 ↗
26. 10.1167/iovs.04-063310.1167/iovs.04-0633 ↗
27. 10.1155/2012/27903710.1155/2012/279037 ↗
28. 10.4103/0974-9233.9211610.4103/0974-9233.92116 ↗
29. 10.1055/s-2001-1860110.1055/s-2001-18601 ↗
30. 10.1111/j.1755-3768.2010.02079.x10.1111/j.1755-3768.2010.02079.x ↗
31. 10.1007/s00417-010-1315-z10.1007/s00417-010-1315-z ↗
32. 10.1155/2012/72832510.1155/2012/728325 ↗
33. Abu El-Asrar AM, Mohammad G, Allegaert E, et al. Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy. Mol Vis. 2018;24:394–406.
34. 10.2337/diabetes.52.2.50610.2337/diabetes.52.2.506 ↗
35. 10.1186/s13020-016-0109-610.1186/s13020-016-0109-6 ↗
36. Xie MS, Zheng YZ, Huang LB, et al. Infliximab relieves blood retinal barrier breakdown through the p38 MAPK pathway in a diabetic rat model. Int J Ophthalmol. 2017;10:1824–1829.
37. Li Y, Bai YJ, Jiang YR, et al. Apelin-13 is an early promoter of cytoskeleton and tight junction in diabetic macular edema via PI-3K/Akt and MAPK/Erk signaling pathways. Biomed Res Int. 2018;2018:3242574.